Find a TenderAwarded
Published 7 Jan 2022, 13:22 GMT

Official UK procurement notice

NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B

Official notice

Authority: NHS England (Central government)·Consortium: 2 public authorities

Framework agreement18 lotsGoodsOpen procedureSME suitable
Sectors: Medical Devices & Pharma (33) Delivery: UK
Framework ceiling (notional)£500,000,000total for 18 lots · framework ceiling, not attributable revenue
Submissions closed 14 Feb 2022awarded 15 Jun 2022
Lots 18see the lot list below
Framework period 2 yrsends 30 Jun 2024 · extension options published · starts 1 Jul 2022

What is being bought18 lots · detail below

Published requirement description

National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B. The framework will commence on 1 July 2022 for a period of 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 moths. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points.

CPV: Blood coagulants

How this framework works

From the published notice
Bids received
4 bids received · 8 suppliers appointed
Framework period
2 yrs from 1 Jul 2022

Lots and requirements (18)Procurement structure

18 lots · all with a published value · evaluation weights differ by lot

Every one of these 18 lots carries the same published figure, £1: it is the framework's maximum for the whole notice, not each lot's own budget, and no share per lot is published. The cards below say ceiling above rather than repeat it.

Lot #1eftrenonacog alfa (rFIX EHL)Cancelled 2 yrsceiling above

eftrenonacog alfa (rFIX EHL)

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement including extension options will be no more than 48 monthsVariant bids: not allowed
Lot #2albutrepenonacog alfa (rFIX EHL)Cancelled 2 yrsceiling above

albutrepenonacog alfa (rFIX EHL)

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed
Lot #3nonacog beta pegol (rFIX EHL)Cancelled 2 yrsceiling above

nonacog beta pegol (rFIX EHL)

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed
Lot #4rFIX - Standard Half LifeCancelled 2 yrsceiling above

rFIX - Standard Half Life

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed
Lot #5Recombinant Factor VIICancelled 2 yrsceiling above

Recombinant Factor VII

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed
Lot #6Porcine Factor VIII - susoctocog alfaCancelled 2 yrsceiling above

Porcine Factor VIII - susoctocog alfa

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed
Lot #7Factor VIII Inhibitor Bypassing FractionCancelled 2 yrsceiling above

Factor VIII Inhibitor Bypassing Fraction

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed
Lot #8Factor IX - High Purity Factor IXCancelled 2 yrsceiling above

Factor IX - High Purity Factor IX

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed
Lot #9Factor XCancelled 2 yrsceiling above

Factor X

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed
Lot #10Factor XIII - Plasma DerivedCancelled 2 yrsceiling above

Factor XIII - Plasma Derived

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed
Lot #11Factor XIII - RecombinantCancelled 2 yrsceiling above

Factor XIII - Recombinant

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed
Lot #12Factor VIII/ von willebrands factorCancelled 2 yrsceiling above

Factor VIII/ von willebrands factor

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed
Lot #13Von willebrands factor - Plasma DerivedCancelled 2 yrsceiling above

Von willebrands factor - Plasma Derived

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed
Lot #14Von willebrands factor - RecombinantCancelled 2 yrsceiling above

Von willebrands factor - Recombinant

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed
Lot #15Fibrinogen ConcentrateCancelled 2 yrsceiling above

Fibrinogen Concentrate

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed
Lot #16Prothrombin Complex driedCancelled 2 yrsceiling above

Prothrombin Complex dried

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed
Lot #17Protein C ConcentrateCancelled 2 yrsceiling above

Protein C Concentrate

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed
Lot #18Fresh Frozen PlasmaCancelled 2 yrsceiling above

Fresh Frozen Plasma

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)
Delivery: UK · ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Option or Options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 monthsVariant bids: not allowed

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
What this means for your bid
  • Price carries 75 points on every lot: a 10% discount moves about 7.5 points.
  • “NHS National Framework Agreement for the supply of products for the…” is a framework: the contest is a place on its panel, not a single contract.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
7 Jan 2022, 13:22 GMT
Last source update
4 Jul 2022, 14:02 BST
Award evaluation window
14 Feb 2022 – …
Authority reference
CM/PHS/19/5576
FTS notice number
2022/S 000-018165
Classification (CPV)
Blood coagulants
Delivery area
UK
Official registry OCID
ocds-h6vhtk-030881 Find a Tender
Contract terms
Electronic trading
e-invoicing allowed · electronic ordering · electronic payment

Publisher note: RESPONDING TO THIS NOTICE:<br/>Any supplier may be disqualified who does not respond to the following in the requisite manner:<br/>1) Submission of expression of interest and procurement specific information<br/>This procurement exercise will be conducted on the eTendering portal at<br/>https://healthfamily.force.com/s/Welcome<br/>Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific<br/>information (if requested) through the eTendering portal as follows:<br/>1.1) If not already registered, Candidatesshould register on the eTendering portal at<br/>https://health-family.force.com/s/Welcome and<br/>click the link to register:<br/>- agree to the user agreement<br/>- populate company details<br/>1.2) Once registered, candidates must register interest as follows:<br/>- log to the portal<br/>- select "Find Opportunities" from the supplier home screen, use the "Sort by:" facility to find this opportunity and select the bold blue title to select <br/>review opportunity details and click "Register Interest"<br/>- as you select the opportunity, you can review documents, send clarification messages,submit the response or decline to respond (if<br/>you decide not to participate in the opportunity)<br/>1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis help desk at supporthealth@<br/>atamis.co.uk or by calling 0800 9956035 for technical assistance when<br/>completing responses.<br/>2) General supplier information.<br/>To manage and assess supplier information the Contracting Authority requests candidates provide their company profile in the Government's Supplier Registration Service (which has replaced sid4gov), as follows:<br/>2.1) If not already registered (the previous sid4gov password, login and details will still be on the system), candidates must go to the<br/>following web page<br/>https://supplierregistration.cabinetoffice.gov.uk and select "Register" at the top of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S®Number, click on the link at the right of the page to obtain a number from D&B.<br/>Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on the system.<br/>2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise.<br/>D&B data will be supplied automatically by D&B.<br/>2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via the message function on the website.<br/>OTHER CONTRACTING AUTHORITIES<br/>The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together<br/>as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or<br/>goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare<br/>or health related services.

How it was run

Official notice
Run through: Atamis (Health Family) · Who buys & how to bid on Atamis
Supplier login requiredLanguage: EN
Access & registration note: Free · one account PER buying organisation portal · password resets come "from Salesforce.com" (check spam)

Tender documents are also served through a separate tool: http://health.atamis.co.uk ↗

Appointment period ends
14 Feb 2022, 13:00 GMT
Submission channel
{"electronicSubmission","written"}
Accepted languages
en
Bids opened
14 Feb 2022, 13:00 GMT
Detailed submission instructions & authority contactsFrom official release

Timeline

14 Feb 2022 → 4 Jul 2022 · 5 dates
  1. Admission / appointment period endsperiod end, not a bid countdown
    14 Feb 2022, 13:00 GMT
  2. Bids opened
    14 Feb 2022, 13:00 GMT
  3. Bids must remain valid until
    15 May 2022, 23:59 BST
  4. Contract starts
    1 Jul 2022, 00:00 BST
  5. Notice published
    4 Jul 2022, 14:02 BST

Notice history

2 events · 2 releases on Find a Tender · since 4 Jul 2022
  1. Status changed to complete
    4 Jul 2022, 14:02 BST
  2. Buyer details updated
    4 Jul 2022, 14:02 BST

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 8admitted to the panel · see the list ↓
Bids received 41 from SMEs
Contracts signed 20latest 15 Jun 2022

25 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

All 20 of these contracts carry the same published figure, £1, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.

  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B p

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B p

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B Lot 1 - eftrenonacog alfa (rFIX EHL)

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active
  • Bleeding Disorders including Haemophilia B

    Signed
    15 Jun 2022
    Value
    ceiling above
    Status
    active

Bid statistics published by the authority

BidsSMEVCSEValid bid range
4bids · 4 electronic · 4 from abroad1——

Contracting authority & participating public bodies

2 public bodies on the notice

NHS England

Contracting authorityCentral GovernmentMinistry or any other national or federal authority, including their regional or local subdivisionsHealth Quarry House, Quarry Hill, Leeds, UK, LS2 7UEContact name, email

Consortium members and other public bodies

Dispute resolution & review bodies

  • The High CourtReview body LondonContact email

Framework contractors & participating bidders

8 commercial parties on the notice
  • Bio Products Laboratory LtdFramework contractor Dagger Lane, Elstree, Elstree, UK, B31 2UQ
  • CSL Behring UK LtdFramework contractor 4 Milton Road, Haywards Heath, Haywards Heath, UK, RH16 1AH
  • LFBFramework contractor Suite 104, Spirella Building, Bridge Road, Letchworth Garden City, UK, SG6 4ET
  • Novo NordiskFramework contractor 3 City Place, Beehive Ring Road, Gatwick, UK, RH6 0PA
  • Octapharma LimitedFramework contractor The Zenith Building, 26 Spring Gardens, Manchester, UK, M2 1AB
  • Pfizer LtdFramework contractor Walton Oaks, Dorking Road, Tadworth, UK, KT20 7NS
  • Sobi (Swedish Orphan Biovitrum Ltd)Framework contractor Suite 2, Riverside 3, Great Abington, UK, CB21 6AD
  • Takeda UK LtdFramework contractor 1 Kingdom Street, London, UK, W2 6BD

Official documents & specifications (2)

Official links; attachments are not copied

Tender pack and attachments

  • Economic and financial selection criteriatenderEconomic and financial selection criteria
  • Technical selection criteriatenderTechnical selection criteria